Publicaciones (62) Publicaciones de MARIA GLORIA SANCHEZ ANTOLIN

2023

  1. Antimigration versus conventional fully covered metal stents in the endoscopic treatment of anastomotic biliary strictures after deceased-donor liver transplantation

    Surgical Endoscopy, Vol. 37, Núm. 9, pp. 6975-6982

2022

  1. Acute liver failure due to anti-tuberculous treatment: when you travel without medical follow-up

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 10, pp. 627-628

  2. Seguimiento del trasplantado hepático en Atención Primaria

    FMC: Formación Médica Continuada en Atención Primaria, Vol. 29, Núm. 5, pp. 261-267

2021

  1. De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors

    European Journal of Gastroenterology and Hepatology, Vol. 33, Núm. 3, pp. 399-406

  2. Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation

    Transplantation, Vol. 105, Núm. 3, pp. 602-607

  3. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt

    Gastroenterologia y Hepatologia, Vol. 44, Núm. 9, pp. 620-627

  4. Role of rapid antigen testing in population‐based sars‐cov‐2 screening

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  5. Validez interna de una prueba rápida de detección de antígenos COVID-19 en una residencia de mayores

    Semergen: revista española de medicina de familia, Núm. 5, pp. 332-336

2020

  1. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

    Antiviral Research, Vol. 174

  2. Hemophagocytic Syndrome as Uncommon Cause of Severe Pancytopenia After Liver Transplantation

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1500-1502

  3. Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1507-1510

  4. Utility of Ethyl-Glucuronide for Evaluation of Abstinence in Patients Presenting for Liver Transplantation

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1450-1452

2019

  1. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 141-149

  2. Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C

    Transplantation Proceedings, Vol. 51, Núm. 1, pp. 74-76

  3. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 9, pp. 579-592

  4. Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation

    Transplantation Proceedings, Vol. 51, Núm. 1, pp. 83-86

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study

    Revista Española de Enfermedades Digestivas, Vol. 110, Núm. 9, pp. 538-543

2017

  1. Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation

    Journal of Hepatology, Vol. 67, Núm. 6, pp. 1168-1176

  2. Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

    Transplant International, Vol. 30, Núm. 10, pp. 1041-1050